Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CTRE vs GMRE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CTRE
CareTrust REIT, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$8.76B
5Y Perf.+111.2%
GMRE
Global Medical REIT Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$94M
5Y Perf.-35.4%

CTRE vs GMRE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CTRE logoCTRE
GMRE logoGMRE
IndustryREIT - Healthcare FacilitiesREIT - Healthcare Facilities
Market Cap$8.76B$94M
Revenue (TTM)$324M$148M
Net Income (TTM)$261M$2M
Gross Margin96.6%68.8%
Operating Margin55.7%24.9%
Forward P/E26.5x595.7x
Total Debt$0.00$654M
Cash & Equiv.$198M$7M

CTRE vs GMRELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CTRE
GMRE
StockMay 20May 26Return
CareTrust REIT, Inc. (CTRE)100211.2+111.2%
Global Medical REIT… (GMRE)10064.6-35.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: CTRE vs GMRE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CTRE leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Global Medical REIT Inc. is the stronger pick specifically for dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
CTRE
CareTrust REIT, Inc.
The Real Estate Income Play

CTRE carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 108.7%, EPS growth 96.3%, 3Y rev CAGR 36.5%
  • Lower volatility, beta 0.14
  • Beta 0.14, yield 3.2%
Best for: growth exposure and sleep-well-at-night
GMRE
Global Medical REIT Inc.
The Real Estate Income Play

GMRE is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 5 yrs, beta 0.48, yield 63.5%
  • 308.1% 10Y total return vs CTRE's 272.9%
  • 63.5% yield, 5-year raise streak, vs CTRE's 3.2%
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCTRE logoCTRE108.7% FFO/revenue growth vs GMRE's -1.8%
ValueCTRE logoCTRELower P/E (26.5x vs 595.7x)
Quality / MarginsCTRE logoCTRE80.6% margin vs GMRE's 1.7%
Stability / SafetyCTRE logoCTREBeta 0.14 vs GMRE's 0.48
DividendsGMRE logoGMRE63.5% yield, 5-year raise streak, vs CTRE's 3.2%
Momentum (1Y)CTRE logoCTRE+40.9% vs GMRE's -0.7%
Efficiency (ROA)CTRE logoCTRE5.1% ROA vs GMRE's 0.2%, ROIC 10.1% vs 2.0%

CTRE vs GMRE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CTRECareTrust REIT, Inc.
FY 2025
Reportable Segment
100.0%$476M
GMREGlobal Medical REIT Inc.

Segment breakdown not available.

CTRE vs GMRE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCTRELAGGINGGMRE

Income & Cash Flow (Last 12 Months)

CTRE leads this category, winning 6 of 6 comparable metrics.

CTRE is the larger business by revenue, generating $324M annually — 2.2x GMRE's $148M. CTRE is the more profitable business, keeping 80.6% of every revenue dollar as net income compared to GMRE's 1.7%. On growth, CTRE holds the edge at +82.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…
RevenueTrailing 12 months$324M$148M
EBITDAEarnings before interest/tax$262M$95M
Net IncomeAfter-tax profit$261M$2M
Free Cash FlowCash after capex$334M$19M
Gross MarginGross profit ÷ Revenue+96.6%+68.8%
Operating MarginEBIT ÷ Revenue+55.7%+24.9%
Net MarginNet income ÷ Revenue+80.6%+1.7%
FCF MarginFCF ÷ Revenue+103.2%+12.6%
Rev. Growth (YoY)Latest quarter vs prior year+82.4%+18.7%
EPS Growth (YoY)Latest quarter vs prior year+66.7%-166.2%
CTRE leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

GMRE leads this category, winning 3 of 5 comparable metrics.

At 25.1x trailing earnings, CTRE trades at a 78% valuation discount to GMRE's 115.3x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than CTRE's 15.2x.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…
Market CapShares × price$8.8B$94M
Enterprise ValueMkt cap + debt − cash$8.6B$741M
Trailing P/EPrice ÷ TTM EPS25.06x115.29x
Forward P/EPrice ÷ next-FY EPS est.26.46x595.67x
PEG RatioP/E ÷ EPS growth rate1.18x
EV / EBITDAEnterprise value multiple15.21x8.35x
Price / SalesMarket cap ÷ Revenue18.39x0.68x
Price / BookPrice ÷ Book value/share1.99x0.17x
Price / FCFMarket cap ÷ FCF22.24x
GMRE leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

CTRE leads this category, winning 8 of 8 comparable metrics.

CTRE delivers a 6.5% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $0 for GMRE. On the Piotroski fundamental quality scale (0–9), CTRE scores 6/9 vs GMRE's 4/9, reflecting solid financial health.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…
ROE (TTM)Return on equity+6.5%+0.5%
ROA (TTM)Return on assets+5.1%+0.2%
ROICReturn on invested capital+10.1%+2.0%
ROCEReturn on capital employed+11.0%+5.3%
Piotroski ScoreFundamental quality 0–964
Debt / EquityFinancial leverage1.18x
Net DebtTotal debt minus cash-$198M$647M
Cash & Equiv.Liquid assets$198M$7M
Total DebtShort + long-term debt$0$654M
Interest CoverageEBIT ÷ Interest expense10.76x1.14x
CTRE leads this category, winning 8 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

CTRE leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in CTRE five years ago would be worth $20,154 today (with dividends reinvested), compared to $8,026 for GMRE. Over the past 12 months, CTRE leads with a +40.9% total return vs GMRE's -0.7%. The 3-year compound annual growth rate (CAGR) favors CTRE at 30.0% vs GMRE's 1.5% — a key indicator of consistent wealth creation.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…
YTD ReturnYear-to-date+9.4%+6.9%
1-Year ReturnPast 12 months+40.9%-0.7%
3-Year ReturnCumulative with dividends+119.5%+4.7%
5-Year ReturnCumulative with dividends+101.5%-19.7%
10-Year ReturnCumulative with dividends+272.9%+308.1%
CAGR (3Y)Annualised 3-year return+30.0%+1.5%
CTRE leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

CTRE leads this category, winning 2 of 2 comparable metrics.

CTRE is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than GMRE's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTRE currently trades 94.3% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…
Beta (5Y)Sensitivity to S&P 5000.14x0.48x
52-Week HighHighest price in past year$41.72$39.93
52-Week LowLowest price in past year$27.72$29.05
% of 52W HighCurrent price vs 52-week peak+94.3%+89.5%
RSI (14)Momentum oscillator 0–10054.752.7
Avg Volume (50D)Average daily shares traded2.5M104K
CTRE leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

GMRE leads this category, winning 2 of 2 comparable metrics.

Wall Street rates CTRE as "Buy" and GMRE as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs 8.0% for CTRE (target: $43). For income investors, GMRE offers the higher dividend yield at 63.51% vs CTRE's 3.23%.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$42.50$40.00
# AnalystsCovering analysts1922
Dividend YieldAnnual dividend ÷ price+3.2%+63.5%
Dividend StreakConsecutive years of raises25
Dividend / ShareAnnual DPS$1.27$22.70
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
GMRE leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CTRE leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GMRE leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallCareTrust REIT, Inc. (CTRE)Leads 4 of 6 categories
Loading custom metrics...

CTRE vs GMRE: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CTRE or GMRE a better buy right now?

For growth investors, CareTrust REIT, Inc.

(CTRE) is the stronger pick with 108. 7% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). CareTrust REIT, Inc. (CTRE) offers the better valuation at 25. 1x trailing P/E (26. 5x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CTRE or GMRE?

On trailing P/E, CareTrust REIT, Inc.

(CTRE) is the cheapest at 25. 1x versus Global Medical REIT Inc. at 115. 3x. On forward P/E, CareTrust REIT, Inc. is actually cheaper at 26. 5x.

03

Which is the better long-term investment — CTRE or GMRE?

Over the past 5 years, CareTrust REIT, Inc.

(CTRE) delivered a total return of +101. 5%, compared to -19. 7% for Global Medical REIT Inc. (GMRE). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus CTRE's +272. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CTRE or GMRE?

By beta (market sensitivity over 5 years), CareTrust REIT, Inc.

(CTRE) is the lower-risk stock at 0. 14β versus Global Medical REIT Inc. 's 0. 48β — meaning GMRE is approximately 251% more volatile than CTRE relative to the S&P 500.

05

Which is growing faster — CTRE or GMRE?

By revenue growth (latest reported year), CareTrust REIT, Inc.

(CTRE) is pulling ahead at 108. 7% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: CareTrust REIT, Inc. grew EPS 96. 3% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CTRE or GMRE?

CareTrust REIT, Inc.

(CTRE) is the more profitable company, earning 67. 3% net margin versus 4. 8% for Global Medical REIT Inc. — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 98. 7% versus 23. 6% for GMRE. At the gross margin level — before operating expenses — CTRE leads at 98. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CTRE or GMRE more undervalued right now?

On forward earnings alone, CareTrust REIT, Inc.

(CTRE) trades at 26. 5x forward P/E versus 595. 7x for Global Medical REIT Inc. — 569. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

08

Which pays a better dividend — CTRE or GMRE?

All stocks in this comparison pay dividends.

Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 3. 2% for CareTrust REIT, Inc. (CTRE).

09

Is CTRE or GMRE better for a retirement portfolio?

For long-horizon retirement investors, CareTrust REIT, Inc.

(CTRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 3. 2% yield, +272. 9% 10Y return). Both have compounded well over 10 years (CTRE: +272. 9%, GMRE: +308. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CTRE and GMRE?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CTRE is a small-cap high-growth stock; GMRE is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CTRE

High-Growth Quality Leader

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 41%
  • Net Margin > 48%
Run This Screen
Stocks Like

GMRE

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 41%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CTRE and GMRE on the metrics below

Revenue Growth>
%
(CTRE: 82.4% · GMRE: 18.7%)
P/E Ratio<
x
(CTRE: 25.1x · GMRE: 115.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.